These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37107062)

  • 1. Should Airway Interstitial Fluid Be Used to Evaluate the Pharmacokinetics of Macrolide Antibiotics for Dose Regimen Determination in Respiratory Infection?
    Wang J; Zhou X; Elazab ST; Park SC; Hsu WH
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of Macrolide Antibiotics and Transport into the Interstitial Fluid: Comparison among Erythromycin, Clarithromycin, and Azithromycin.
    Kobuchi S; Kabata T; Maeda K; Ito Y; Sakaeda T
    Antibiotics (Basel); 2020 Apr; 9(4):. PubMed ID: 32331283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of bovine respiratory disease on the pharmacokinetics of danofloxacin and tulathromycin in different ages of calves.
    Mzyk DA; Bublitz CM; Martinez MN; Davis JL; Baynes RE; Smith GW
    PLoS One; 2019; 14(6):e0218864. PubMed ID: 31233558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients.
    Busse D; Simon P; Schmitt L; Petroff D; Dorn C; Dietrich A; Zeitlinger M; Huisinga W; Michelet R; Wrigge H; Kloft C
    Clin Pharmacokinet; 2022 May; 61(5):655-672. PubMed ID: 34894344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of soft tissue drug concentrations in morbidly obese and non-obese patients - A prospective, parallel group, open-labeled, controlled, phase IV, single center clinical trial.
    Simon P; Petroff D; Dorn C; Ehmann L; Kloft C; Prettin C; Dietrich A; Zeitlinger M; Kees F; Wrigge H
    Contemp Clin Trials Commun; 2019 Sep; 15():100375. PubMed ID: 31193565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal macrolide resistance--myth or reality?
    Amsden GW
    J Antimicrob Chemother; 1999 Jul; 44(1):1-6. PubMed ID: 10459803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision.
    Chua HC; Tse A; Smith NM; Mergenhagen KA; Cha R; Tsuji BT
    Int J Antimicrob Agents; 2021 Mar; 57(3):106269. PubMed ID: 33358761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline pharmacokinetics and pharmacodynamics in dogs: dosage recommendations for treatment of meticillin-resistant Staphylococcus pseudintermedius infections.
    Maaland MG; Guardabassi L; Papich MG
    Vet Dermatol; 2014 Jun; 25(3):182-e47. PubMed ID: 24840325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective.
    Zeitlinger M; Wagner CC; Heinisch B
    Clin Pharmacokinet; 2009; 48(1):23-38. PubMed ID: 19071882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carprofen pharmacokinetics in plasma and in control and inflamed canine tissue fluid using in vivo ultrafiltration.
    Messenger KM; Wofford JA; Papich MG
    J Vet Pharmacol Ther; 2016 Feb; 39(1):32-9. PubMed ID: 25958925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.
    Čipčić Paljetak H; Verbanac D; Padovan J; Dominis-Kramarić M; Kelnerić Ž; Perić M; Banjanac M; Ergović G; Simon N; Broskey J; Holmes DJ; Eraković Haber V
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5337-48. PubMed ID: 27353268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide antibiotics for cystic fibrosis.
    Southern KW; Barker PM; Solis-Moya A; Patel L
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD002203. PubMed ID: 23152214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide antibiotics for cystic fibrosis.
    Southern KW; Barker PM; Solis-Moya A; Patel L
    Cochrane Database Syst Rev; 2011 Dec; (12):CD002203. PubMed ID: 22161368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why We May Need Higher Doses of Beta-Lactam Antibiotics: Introducing the 'Maximum Tolerable Dose'.
    Dhaese SAM; Hoste EA; De Waele JJ
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring.
    Kiang TK; Häfeli UO; Ensom MH
    Clin Pharmacokinet; 2014 Aug; 53(8):695-730. PubMed ID: 24972859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating target-mediated drug disposition in a minimal physiologically-based pharmacokinetic model for monoclonal antibodies.
    Cao Y; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2014 Aug; 41(4):375-87. PubMed ID: 25077917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Cefazolin Dosing in Women With Body Mass Index >35 kg·m-2 Undergoing Cesarean Delivery: A Pharmacokinetic Study of Plasma and Interstitial Fluid.
    Eley VA; Christensen R; Ryan R; Jackson D; Parker SL; Smith M; van Zundert AA; Wallis SC; Lipman J; Roberts JA
    Anesth Analg; 2020 Jul; 131(1):199-207. PubMed ID: 32250982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of appropriate antimicrobial dosing: pharmacokinetic and pharmacodynamic considerations.
    Preston SL
    Ann Pharmacother; 2004 Sep; 38(9 Suppl):S14-8. PubMed ID: 15226489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy?
    Varghese JM; Jarrett P; Wallis SC; Boots RJ; Kirkpatrick CM; Lipman J; Roberts JA
    J Antimicrob Chemother; 2015 Feb; 70(2):528-33. PubMed ID: 25336163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events in people taking macrolide antibiotics versus placebo for any indication.
    Hansen MP; Scott AM; McCullough A; Thorning S; Aronson JK; Beller EM; Glasziou PP; Hoffmann TC; Clark J; Del Mar CB
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011825. PubMed ID: 30656650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.